Synapse - Center for Hematologic Malignancies

Results (13546)

Neuroblastoma and Wilms' tumor

Book Section

Spierer, M.; Tereffe, W.; Wolden, S.
In Leibel, S. A.; Phillips, T. L. (Eds.) Leibel and Phillips Textbook of Radiation Oncology. 2nd ed (2004)

Fulltext@MSK | Save

Induction of mitotic defect is a novel anti-tumor mechanism of histone deacetylase inhibitor suberoylanilide hydroxamic acid

Meeting Abstract

Xu, W.; Perez, G.; Gui, C.; Thapi, D.; Ngo, L.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
Cancer Research (2004)

Fulltext@MSK | Save

The paradoxical effect of glucocorticoid-induced tumor necrosis factor receptor family-related gene (GITR) stimulation on alloreactive CD4 and CD8 T cells and the development of GVHD

Meeting Abstract

Ramirez-Montagut, T.; Muriglan, S. J.; Alpdogan, O.; Eng, J. M.; Hubbard, V. M.; Kochman, A. A.; Houghton, A. N.; van den Brink, M. R. M.
Cancer Research (2004)

Fulltext@MSK | Save

Novel murine xenograft models of human osteosarcoma and in vivo response to gemcitabine, L-alanosine, and herceptin

Meeting Abstract

Kolb, E. A.; Wenzel, B.; Merola, P.; Yang, R.; Sowers, R.; Steinherz, P. G.; Healey, J.; Huvos, A. G.; Meyers, P. A.; Gorlick, R.
Cancer Research (2004)

Fulltext@MSK | Save

Histone deacetylase inhibitor activation of p21 involves changes in promoter associated proteins, including HDAC1

Meeting Abstract

Gui, C.; Ngo, L.; Xu, W.; Thapi, D.; Perez, G. V.; Richon, V. M.; Rifkind, R. A.; Marks, P. A.
Cancer Research (2004)

Fulltext@MSK | Save

A successful prime-boost immunization strategy in a tumor model: Targeting tyrosinase in melanoma

Meeting Abstract

Goldberg, S. M.; Guevara-Patiño, J. A.; Gardner, J. P.; Montgomery, S. C.; Perales, M. A.; Donovan, G. P.; Olson, W. C.; Wolchok, J. D.
Cancer Research (2004)

Fulltext@MSK | Save

Combinatorial targeting of oncogenesis via a novel rationally designed Hsp90 inhibitor

Meeting Abstract

Chiosis, G.; Solit, D.; Vilenchik, M.; Rosen, N.
Cancer Research (2004)

Fulltext@MSK | Save

Frequency of molecular and PET/CT complete remissions in patients with multiple myeloma after autologous followed by reduced-intensity allogeneic stem cell transplants

Meeting Abstract

Zhou, P.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Miller, K.; Pandit-Taskar, N.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
Blood (2004)

Fulltext@MSK | Save

Clinical outcomes and cost of outpatient community-based treatment for rituximab refractory non-Hodgkins Lymphoma (NHL) patients

Meeting Abstract

Zelenetz, A. D.; Tang, B. X.; Frame, D.; Nalysnyk, L.; Cella, C.; Noel, J. K.
Blood (2004)

Fulltext@MSK | Save

Langerhans cells modified by gene transfer of full length CMV pp65 are more potent inducers of cytolytic T lymphocytes in a CD4-dependent manner than either CMV p495 gene-modified or p495 peptide-pulsed Langerhans cells

Meeting Abstract

Yuan, J.; Latouche, J. B.; Hodges, J.; Heller, G.; Riviere, I.; Sadelain, M.; Young, J. W.
Molecular Therapy (2004)

Fulltext@MSK | Save